Filter by:

Beyond genes: EpiSwitch® and Orion platform-powered 3D genome architecture biomarkers reveal shared biology across ME/CFS, long COVID, PTSD, rheumatoid arthritis, and multiple sclerosis.

Journal of Translational Medicine |
View Article

3D Genomics

ME/CFS

EpiSwitch Orion

Development and Validation of Blood-Based Diagnostic Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Using EpiSwitch® 3-Dimensional Genomic Regulatory Immuno-Genetic Profiling

Journal of Translational Medicine |
View Article

ME/CFS

Clinical Utility of the EpiSwitch CiRT Test to Guide Immunotherapy Across Solid Tumors: Interim Results from the PROWES Study

Cancers |
View Article

Cancer

3D Genomics

Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100

Cancers |
View Article

Cancer

EpiSwitch PSE Blood Test Reduces Unnecessary Prostate Biopsies: A Real-World Clinical Utility Study

Cancers |
View Article

Cancer